These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
316 related items for PubMed ID: 7906563
1. Factor XIIIa binding to activated platelets is mediated through activation of glycoprotein IIb-IIIa. Cox AD, Devine DV. Blood; 1994 Feb 15; 83(4):1006-16. PubMed ID: 7906563 [Abstract] [Full Text] [Related]
2. A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex. Coller BS. J Clin Invest; 1985 Jul 15; 76(1):101-8. PubMed ID: 2991335 [Abstract] [Full Text] [Related]
3. Studies on the binding of an alloimmune and two murine monoclonal antibodies to the platelet glycoprotein IIb-IIIa complex receptor. Coller BS, Peerschke EI, Seligsohn U, Scudder LE, Nurden AT, Rosa JP. J Lab Clin Med; 1986 Apr 15; 107(4):384-92. PubMed ID: 2420911 [Abstract] [Full Text] [Related]
4. Glycoprotein IIb-IIIa and RGD(S) are not important for fibronectin-dependent platelet adhesion under flow conditions. Nievelstein PF, Sixma JJ. Blood; 1988 Jul 15; 72(1):82-8. PubMed ID: 2968824 [Abstract] [Full Text] [Related]
5. How vitronectin binds to activated glycoprotein IIb-IIIa complex and its function in platelet aggregation. Mohri H, Ohkubo T. Am J Clin Pathol; 1991 Nov 15; 96(5):605-9. PubMed ID: 1719797 [Abstract] [Full Text] [Related]
6. Aggregation of chymotrypsin-treated thrombasthenic platelets is mediated by fibrinogen binding to glycoproteins IIb and IIIa. Niewiarowski S, Kornecki E, Hershock D, Tuszynski GP, Bennett JS, Soria C, Soria J, Dunn F, Pidard D, Kieffer N. J Lab Clin Med; 1985 Dec 15; 106(6):651-60. PubMed ID: 2999274 [Abstract] [Full Text] [Related]
7. Binding of plasma factor XIII to thrombin-receptor activated human platelets. Nagy B, Simon Z, Bagoly Z, Muszbek L, Kappelmayer J. Thromb Haemost; 2009 Jul 15; 102(1):83-9. PubMed ID: 19572072 [Abstract] [Full Text] [Related]
8. A defect of platelet aggregation associated with an abnormal distribution of glycoprotein IIb-IIIa complexes within the platelet: the cause of a lifelong bleeding disorder. Hardisty R, Pidard D, Cox A, Nokes T, Legrand C, Bouillot C, Pannocchia A, Heilmann E, Hourdillé P, Bellucci S. Blood; 1992 Aug 01; 80(3):696-708. PubMed ID: 1638023 [Abstract] [Full Text] [Related]
9. Tyrosine phosphorylation of the novel protein-tyrosine kinase RAFTK during an early phase of platelet activation by an integrin glycoprotein IIb-IIIa-independent mechanism. Raja S, Avraham S, Avraham H. J Biol Chem; 1997 Apr 18; 272(16):10941-7. PubMed ID: 9099753 [Abstract] [Full Text] [Related]
10. Endogenous platelet fibrinogen surface expression on activated platelets. Gralnick HR, Williams S, McKeown L, Connaghan G, Shafer B, Hansmann K, Vail M, Fenton J. J Lab Clin Med; 1991 Dec 18; 118(6):604-13. PubMed ID: 1744509 [Abstract] [Full Text] [Related]
11. Platelet-derived microparticle formation involves glycoprotein IIb-IIIa. Inhibition by RGDS and a Glanzmann's thrombasthenia defect. Gemmell CH, Sefton MV, Yeo EL. J Biol Chem; 1993 Jul 15; 268(20):14586-9. PubMed ID: 8325838 [Abstract] [Full Text] [Related]
15. Characterization of an anti-thrombospondin monoclonal antibody (P8) that inhibits human blood platelet functions. Normal binding of P8 to thrombin-activated Glanzmann thrombasthenic platelets. Boukerche H, McGregor JL. Eur J Biochem; 1988 Jan 15; 171(1-2):383-92. PubMed ID: 3338471 [Abstract] [Full Text] [Related]
16. Platelet fibrinogen and vitronectin in Glanzmann thrombasthenia: evidence consistent with specific roles for glycoprotein IIb/IIIA and alpha v beta 3 integrins in platelet protein trafficking. Coller BS, Seligsohn U, West SM, Scudder LE, Norton KJ. Blood; 1991 Nov 15; 78(10):2603-10. PubMed ID: 1726706 [Abstract] [Full Text] [Related]